Rempart Asset Management Inc. Has $20.89 Million Stake in Colgate-Palmolive Company $CL

Rempart Asset Management Inc. boosted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 3.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 264,418 shares of the company’s stock after buying an additional 8,445 shares during the quarter. Colgate-Palmolive accounts for 3.9% of Rempart Asset Management Inc.’s investment portfolio, making the stock its 13th biggest holding. Rempart Asset Management Inc.’s holdings in Colgate-Palmolive were worth $20,894,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP grew its holdings in Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares during the period. Schnieders Capital Management LLC. increased its position in Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after buying an additional 245 shares during the last quarter. Global Retirement Partners LLC acquired a new position in Colgate-Palmolive during the second quarter worth approximately $655,000. Finally, CreativeOne Wealth LLC raised its stake in Colgate-Palmolive by 4.4% in the second quarter. CreativeOne Wealth LLC now owns 15,259 shares of the company’s stock valued at $1,387,000 after buying an additional 639 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. This trade represents a 59.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 over the last ninety days. Corporate insiders own 0.34% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CL shares. Jefferies Financial Group raised their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Bank of America increased their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Evercore lifted their price objective on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, February 2nd. Finally, Barclays upped their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Trading Up 1.0%

Shares of NYSE:CL opened at $85.35 on Thursday. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The business has a 50 day moving average of $91.12 and a 200-day moving average of $83.37. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The stock has a market cap of $68.80 billion, a PE ratio of 32.58, a P/E/G ratio of 3.79 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 earnings per share. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.5%. The ex-dividend date is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.